Chengxuan Qiu1, Bengt Winblad, Johan Fastbom, Laura Fratiglioni. 1. Aging Research Center, Division of Geriatric Epidemiology and Medicine, Department of Neurotec, Karolinska Institutet and the Stockholm Gerontology Research Center, Stockholm, Sweden. chengxuan.qiu@neurotec.ki.se
Abstract
OBJECTIVE: To study the hypotheses that APOE-epsilon4 allele may interact with blood pressure to affect Alzheimer's disease (AD) occurrence and that antihypertensive therapy could modify such an effect. METHODS: A dementia-free cohort of 966 community-dwelling persons aged 75 years and older in Stockholm, Sweden was followed to detect patients with AD using the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) diagnostic criteria. Data were analyzed using Cox proportional hazards models with adjustment for several potential confounders. RESULTS: During a 6-year follow-up period, AD was diagnosed in 204 persons. APOE-epsilon4 allele, high systolic pressure (> or = 140 mm Hg), and low diastolic pressure (<70 mm Hg) were associated with an increased risk of AD. APOE-epsilon4 allele combined with low diastolic pressure greatly increased the risk of AD independent of antihypertensive drug use. Antihypertensive therapy significantly reduced the risk of AD regardless of APOE-epsilon4 status and counteracted the combined risk effect of the epsilon4 allele with high systolic pressure on the disease. CONCLUSIONS: Elderly people with genetic susceptibility for Alzheimer's disease may experience a further increased disease risk if they have either high systolic pressure or low diastolic pressure. Antihypertensive therapy decreases the risk of Alzheimer's disease exerted by the APOE-epsilon4 allele.
OBJECTIVE: To study the hypotheses that APOE-epsilon4 allele may interact with blood pressure to affect Alzheimer's disease (AD) occurrence and that antihypertensive therapy could modify such an effect. METHODS: A dementia-free cohort of 966 community-dwelling persons aged 75 years and older in Stockholm, Sweden was followed to detect patients with AD using the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) diagnostic criteria. Data were analyzed using Cox proportional hazards models with adjustment for several potential confounders. RESULTS: During a 6-year follow-up period, AD was diagnosed in 204 persons. APOE-epsilon4 allele, high systolic pressure (> or = 140 mm Hg), and low diastolic pressure (<70 mm Hg) were associated with an increased risk of AD. APOE-epsilon4 allele combined with low diastolic pressure greatly increased the risk of AD independent of antihypertensive drug use. Antihypertensive therapy significantly reduced the risk of AD regardless of APOE-epsilon4 status and counteracted the combined risk effect of the epsilon4 allele with high systolic pressure on the disease. CONCLUSIONS: Elderly people with genetic susceptibility for Alzheimer's disease may experience a further increased disease risk if they have either high systolic pressure or low diastolic pressure. Antihypertensive therapy decreases the risk of Alzheimer's disease exerted by the APOE-epsilon4 allele.
Authors: Terrie Vasilopoulos; William S Kremen; Kathleen Kim; Matthew S Panizzon; Phyllis K Stein; Hong Xian; Michael D Grant; Michael J Lyons; Rosemary Toomey; Lindon J Eaves; Carol E Franz; Kristen C Jacobson Journal: Behav Genet Date: 2011-06-19 Impact factor: 2.805
Authors: Jessica B S Langbaum; Kewei Chen; Lenore J Launer; Adam S Fleisher; Wendy Lee; Xiaofen Liu; Hillary D Protas; Stephanie A Reeder; Daniel Bandy; Meixiang Yu; Richard J Caselli; Eric M Reiman Journal: Neurobiol Aging Date: 2011-08-06 Impact factor: 4.673
Authors: David J Llewellyn; Iain A Lang; Fiona E Matthews; Brenda L Plassman; Mary Am Rogers; Lewis B Morgenstern; Gwenith G Fisher; Mohammed U Kabeto; Kenneth M Langa Journal: Alzheimers Res Ther Date: 2010-06-24 Impact factor: 6.982
Authors: Correne A DeCarlo; Stuart W S MacDonald; David Vergote; Jack Jhamandas; David Westaway; Roger A Dixon Journal: J Gerontol B Psychol Sci Soc Sci Date: 2015-09-11 Impact factor: 4.077
Authors: Weiying Dai; Oscar L Lopez; Owen T Carmichael; James T Becker; Lewis H Kuller; H Michael Gach Journal: Stroke Date: 2008-01-03 Impact factor: 7.914